Alirocumab is a human monoclonal antibody designed for the treatment of hypercholesterolemia. This therapeutic is also known by the codes REGN727 and SAR236553.This drug was discovered by Regeneron Pharmaceuticals and is being co-developed by Regeneron and Sanofi.
This page contains content from the copyrighted Wikipedia article "Alirocumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.